Sirtuin mRNAs and NBR2 emerge as candidate biomarkers and contribute to the progression of prostate cells via secreted extracellular vesicles
Late detection remains a major challenge to the successful treatment of prostate cancer (PCa), as current biomarkers show low sensitivity and specificity for the early detection of the disease. Given that extracellular vesicles (EVs) secreted by cells contain a wide range of bioactive molecules with biomarker potential, we determined the biomarker potential and functional contributions of SIRT1–7 mRNA, NBR2 , and PCGEM1 in prostate cells via their secreted EVs. EVs were isolated by ultrafiltration and characterised by nanoparticle tracking analysis and Western blotting. Expressions of SIRT1–7 mRNA, NBR2 , and PCGEM1 were quantified by qRT-PCR assays. The functional contributions of these molecules via EVs were determined by apoptosis, necrosis, proliferation, and migration assays. We identified diagnostic and prognostic molecular signatures of sirtuin mRNAs and NBR2 , which differed between the PCa cells and their secreted EVs. Among the potential biomarkers identified, SIRT2 , 3 , 4 , and 7 mRNA showed the highest biomarker potential in PCa-derived EVs. Through functional assays, we demonstrated that sirtuin mRNA-rich PCa-derived EVs increased apoptosis, long-term proliferation, and migration of PNT-2 cells. Overall, we demonstrated, for the first time, that sirtuin mRNAs and NBR2 serve both biomarker and functional purposes for prostate cells via secreted EVs.
Authors
- Cosmos Ifeanyi Onyiba (ORCID: https://orcid.org/0000-0001-9563-4820)
- Judith Weidenhofer
- Christopher J. Scarlett
Institutions
- Hunter Medical Research Institute (AU)
- University of Newcastle Australia (AU)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-20
- DOI
- https://doi.org/10.1038/s41598-026-81548-0
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00